{"id":"bladder-instillation-with-triamcinolone-acetonide","safety":{"commonSideEffects":[{"rate":null,"effect":"Dysuria"},{"rate":null,"effect":"Urinary frequency"},{"rate":null,"effect":"Hematuria"},{"rate":null,"effect":"Local bladder irritation"},{"rate":null,"effect":"Urinary tract infection"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Triamcinolone acetonide is a corticosteroid that exerts anti-inflammatory and immunosuppressive effects when instilled directly into the bladder. By local delivery, it reduces inflammatory cytokine production, decreases immune cell infiltration, and suppresses aberrant bladder mucosa responses. This localized approach minimizes systemic steroid exposure while targeting bladder-specific pathology.","oneSentence":"Triamcinolone acetonide delivered directly into the bladder reduces inflammation and suppresses local immune responses in bladder tissue.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:04:31.074Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Interstitial cystitis/bladder pain syndrome"},{"name":"Bladder inflammation or cystitis"}]},"trialDetails":[{"nctId":"NCT02870738","phase":"PHASE2","title":"Bladder Directed vs. Pelvic Floor Therapy in IC/BPS","status":"ACTIVE_NOT_RECRUITING","sponsor":"Corewell Health East","startDate":"2017-04-21","conditions":"Cystitis, Interstitial, Painful Bladder Syndrome","enrollment":128},{"nctId":"NCT05223244","phase":"PHASE4","title":"Bladder Capacity as Objective Measure of Intravesical Treatment of Newly Diagnosed IC","status":"COMPLETED","sponsor":"Endeavor Health","startDate":"2011-10-01","conditions":"Interstitial Cystitis, Painful Bladder Syndrome","enrollment":83},{"nctId":"NCT03463915","phase":"PHASE3","title":"Clinical Trial Comparing Two Bladder Instillations for IC/BPS","status":"COMPLETED","sponsor":"Olivia Cardenas-Trowers, M.D.","startDate":"2019-01-25","conditions":"Interstitial Cystitis, Bladder Pain Syndrome","enrollment":90}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Bladder instillation WITH triamcinolone acetonide","genericName":"Bladder instillation WITH triamcinolone acetonide","companyName":"Olivia Cardenas-Trowers, M.D.","companyId":"olivia-cardenas-trowers-m-d","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Triamcinolone acetonide delivered directly into the bladder reduces inflammation and suppresses local immune responses in bladder tissue. Used for Interstitial cystitis/bladder pain syndrome, Bladder inflammation or cystitis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}